TTrialPathMatch Me to Trials
← Back to trials
RecruitingDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Gastroparesis With Diabetes Mellitus

Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

A pilot study to evaluate and compare glucose metrics using a real-time continuous glucose monitor (FreeStyle Libre 3 sensor) between patients with diabetes and gastroparesis and those with diabetes without gastroparesis.

Sponsor: Samita Garg

You may qualify if…

  • ✓ Over the age of 18 years.
  • ✓ Hemoglobin A1c ≤11% within the last 6 months.
  • ✓ Patients with diagnosis of type 1 Diabetes or type 2 Diabetes for at least one year.
  • ✓ Normal thyroid-stimulating hormone (TSH) within the last year.
  • ✓ No episodes of diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic Status (HHS), or hypoglycemia in the past 2 weeks requiring ER visit or hospitalization.
  • ✓ Symptoms of gastroparesis have been present for at least the past 3 months, in patients with gastroparesis.
  • ✓ In patients with gastroparesis, documented delayed gastric emptying on scintigraphy and/or wireless motility capsule (Smart Pill) as defined by greater than 10% retention at 4 hours or greater than 4-hour gastric transit time (GTT) in the past five years.
  • ✓ Patients using a Smartphone (iPhone or Android) compatible with LibreView App.

You may not qualify if…

  • ✕ Hemoglobin A1c of \>11% at enrollment.
  • ✕ Advanced chronic kidney disease (serum creatinine of \>2 mg/dL or estimated glomerular filtration rate (eGFR) \<30mL/min/1.73m² using Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula).
  • ✕ Advanced and significant cardiovascular disease or unstable angina.
  • ✕ Advanced liver disease that may affect glucose profiles.
  • ✕ Post-transplant patients.
  • ✕ History of gastric surgery.
  • ✕ Patients with symptoms secondary to celiac disease (e.g. diarrhea, nausea, vomiting, abdominal pain) at the time of the enrollment.
  • ✕ Pregnancy or women of reproductive age group not taking adequate precautions for pregnancy for 28 days.

Where it's recruiting

Ohio

Cleveland

Source: ClinicalTrials.gov · NCT06046833 · last updated 2026-08-03

Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or · TrialPath